معرفی
Professor Sunil Lakhani is a leading Molecular Breast Pathologist at the University of Queensland Centre for Clinical Research (UQCCR) and Executive Director of Research Pathology Queensland. He serves as a Conjoint Professorial Research Fellow and Staff Specialist in Anatomical Pathology. Formerly, he was Professor of Breast Pathology at The Institute of Cancer Research and The Royal Marsden Hospital in London, UK.
His research focuses on lobular carcinoma, familial breast cancer, basal phenotype tumors, and therapeutic development for brain metastases. He leads the Molecular Breast Group and contributes to WHO Tumour Classification projects. His recent work explores extracellular vesicle nanomedicine, immune checkpoint markers, and molecular profiling for precision oncology.
Key scientific contributions include serving as
- Series Editor for WHO Tumour Classification Books
- Editorial Board Member of pathology journals
- Co-developer of the LobSig prognostic model
Prominent article themes:
- 2025: ROS1 biomarkers, fibroepithelial lesion diagnostics, phyllodes tumor criteria
- 2024: Epigenetic signatures, placental glucose response, PD-L1 scoring
- 2023: ERK5 isoforms, DNA methylation in phyllodes tumors
